ArticleScientific reports2021

Understanding the antiviral effects of RNAi-based therapy in HBeAg-positive chronic hepatitis B infection.

Sarah Kadelka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.